8-K: Alphatec Holdings Reports Strong 2024 Results, Projects Continued Growth in 2025

Alphatec Holdings announces a 27% increase in full-year 2024 revenue to $612 million and forecasts approximately $732 million in revenue for 2025.

Summary

• Alphatec Holdings, Inc. (ATEC) reported its financial results for the fourth quarter and full year ended December 31, 2024.
• Full year 2024 total revenue grew by 27% to $612 million.
• The company anticipates total revenue for the fiscal year ending December 31, 2025, to be approximately $732 million, reflecting a growth of about 20% compared to 2024.
• This includes surgical revenue of approximately $657 million and EOS revenue of approximately $75 million.
• The company expects adjusted EBITDA of approximately $75 million for 2025, contributing to positive free cash flow.
• GAAP gross margin was 69% for both the quarter and the full year 2024.
• Non-GAAP gross margin was 70% for both the quarter and the full year 2024.
• GAAP net loss was ($33) million for the quarter and ($162) million for the full year 2024.
• Non-GAAP adjusted EBITDA was $21 million for the quarter and $31 million for the full year 2024.
• The company's ending cash balance was $139 million.

Sentiment

Score: 7

Explanation: The sentiment is positive due to strong revenue growth, expansion into new markets, and positive projections for 2025. However, the GAAP net loss and high operating expenses temper the overall sentiment.

Positives

• ATEC achieved a 27% increase in full-year 2024 revenue, reaching $612 million.
• The company is projecting a 20% revenue growth for 2025, with an estimated $732 million in total revenue.
• ATEC anticipates positive free cash flow for the full year 2025.
• Surgical revenue experienced a 28% growth in Q4 2024.
• The company successfully entered the Japanese market.
• ATEC's non-GAAP gross margin remained strong at 70% for both the quarter and the full year 2024.

Negatives

• The company reported a GAAP net loss of ($162) million for the full year 2024.
• Operating expenses remain high at $560 million for the full year 2024.

Risks

• The company's forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
• These risks include the uncertainty of success in developing new products, the ability to execute its strategic operating plan, and the acceptance of the company's products by the surgeon community.
• Other risks include failure to obtain regulatory clearance, continuation of favorable third-party reimbursement, and the company's ability to compete with other products or emerging technologies.

Future Outlook

The company expects total revenue for 2025 to approximate $732 million, with adjusted EBITDA of approximately $75 million, leading to positive free cash flow.

Management Comments

• Pat Miles, Chairman and Chief Executive Officer, stated that ATEC remains focused on revolutionizing spine care and that the coming years will be their best yet.
• He also mentioned that the company is expanding its influence in deformity through EOS-integrated, procedure-specific technologies and is thrilled to have performed their first surgeries in Japan.

Industry Context

ATEC, as the largest pure-play spine company, is focusing on growth and innovation while some in the industry are choosing to capitulate, according to management.

Comparison to Industry Standards

• While specific competitor comparisons aren't provided, the document highlights ATEC's focus on innovation and growth in the spine surgery market, contrasting with companies that may be scaling back.
• ATEC's revenue growth of 27% in 2024 suggests a strong market position and effective strategy compared to industry averages.
• The company's expansion into Japan, the world's second-largest spine market, positions it for further growth and market share gains.

Stakeholder Impact

• Shareholders can expect continued growth and potential for increased profitability.
• Employees may benefit from the company's expansion and innovation efforts.
• Customers (surgeons) will have access to new technologies and solutions for spine surgery.
• Suppliers may see increased demand for their products and services.
• Creditors may view the company as a stable and growing entity.

Next Steps

• The company will host a live webcast to discuss the financial results.
• ATEC will continue to focus on developing new approaches that integrate with its AlphaInformatiX Platform.
• The company will continue to expand its influence in deformity through EOS-integrated, procedure-specific technologies.

Key Dates